| 2024 |
QuidelOrtho Corporation
|
Director, President and Chief Executive Officer |
12.1 M |
- |
| 2023 |
QuidelOrtho Corporation
|
Director, President and Chief Executive Officer |
- |
- |
| 2022 |
QuidelOrtho Corporation
|
Director, President and Chief Executive Officer |
13.1 M |
136.0 % |
| 2021 |
QuidelOrtho Corporation
|
- |
5.5 M |
-22.7 % |
| 2021 |
QuidelOrtho Corporation
|
Director, President and Chief Executive Officer |
5.5 M |
-22.7 % |
| 2020 |
QuidelOrtho Corporation
|
Director, President and Chief Executive Officer |
7.2 M |
72.2 % |
| 2020 |
QuidelOrtho Corporation
|
- |
7.2 M |
72.2 % |
| 2020 |
QuidelOrtho Corporation
|
- |
7.2 M |
72.2 % |
| 2019 |
QuidelOrtho Corporation
|
Director, President and Chief Executive Officer |
4.6 M |
35.3 % |
| 2019 |
QuidelOrtho Corporation
|
- |
4.2 M |
21.8 % |
| 2019 |
QuidelOrtho Corporation
|
- |
4.2 M |
21.8 % |
| 2018 |
QuidelOrtho Corporation
|
- |
3.4 M |
32.4 % |
| 2018 |
QuidelOrtho Corporation
|
- |
3.4 M |
32.4 % |
| 2018 |
QuidelOrtho Corporation
|
Director, President and Chief Executive Officer |
3.4 M |
32.4 % |
| 2017 |
QuidelOrtho Corporation
|
- |
2.6 M |
46.4 % |
| 2017 |
QuidelOrtho Corporation
|
- |
2.6 M |
46.4 % |
| 2017 |
QuidelOrtho Corporation
|
Director, President and Chief Executive Officer |
2.6 M |
46.4 % |
| 2016 |
QuidelOrtho Corporation
|
- |
1.8 M |
-17.8 % |
| 2016 |
QuidelOrtho Corporation
|
Director, President and Chief Executive Officer |
1.8 M |
-17.8 % |
| 2016 |
QuidelOrtho Corporation
|
- |
1.8 M |
-17.8 % |
| 2015 |
QuidelOrtho Corporation
|
- |
2.1 M |
4.4 % |
| 2015 |
QuidelOrtho Corporation
|
- |
2.1 M |
4.4 % |
| 2015 |
QuidelOrtho Corporation
|
Director, President and Chief Executive Officer |
2.1 M |
4.4 % |
| 2014 |
QuidelOrtho Corporation
|
- |
2.1 M |
-8.6 % |
| 2014 |
QuidelOrtho Corporation
|
- |
2.1 M |
-8.6 % |
| 2014 |
QuidelOrtho Corporation
|
Director, President and Chief Executive Officer |
2.1 M |
-8.6 % |
| 2013 |
QuidelOrtho Corporation
|
- |
2.3 M |
36.4 % |
| 2013 |
QuidelOrtho Corporation
|
Director, President and Chief Executive Officer |
2.3 M |
36.4 % |
| 2013 |
QuidelOrtho Corporation
|
- |
2.3 M |
36.4 % |
| 2012 |
QuidelOrtho Corporation
|
- |
1.7 M |
-5.8 % |
| 2012 |
QuidelOrtho Corporation
|
- |
1.7 M |
-5.8 % |
| 2012 |
QuidelOrtho Corporation
|
Director, President and Chief Executive Officer |
1.7 M |
-5.8 % |
| 2011 |
QuidelOrtho Corporation
|
- |
1.8 M |
35.3 % |
| 2011 |
QuidelOrtho Corporation
|
- |
1.8 M |
35.3 % |
| 2011 |
QuidelOrtho Corporation
|
Director, President and Chief Executive Officer |
1.8 M |
35.3 % |
| 2010 |
QuidelOrtho Corporation
|
- |
1.3 M |
-81.3 % |
| 2010 |
QuidelOrtho Corporation
|
President, Chief Executive Officer and Director |
1.3 M |
-81.3 % |
| 2010 |
QuidelOrtho Corporation
|
- |
1.3 M |
-81.3 % |
| 2009 |
QuidelOrtho Corporation
|
- |
6.9 M |
- |
| 2009 |
QuidelOrtho Corporation
|
President, Chief Executive Officer and Director |
6.9 M |
- |
| 2009 |
QuidelOrtho Corporation
|
- |
6.9 M |
- |
| 2008 |
QuidelOrtho Corporation
|
President, Chief Executive Officer and Director |
- |
- |
| 2007 |
Abbott Laboratories
|
Vice President, Molecular Global Commercial Operations |
- |
- |
| 2006 |
Abbott Laboratories
|
Vice President, Molecular Global Commercial Operations |
- |
- |
| 2005 |
Abbott Laboratories
|
Vice President, Molecular Global Commercial Operations |
- |
- |